Nakajima, M., Hazama, S., Tamada, K., Udaka, K., Kouki, Y., Uematsu, T., . . . Nagano, H. (2020). A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial. Cancer Immunol Immunother.
Citación estilo ChicagoNakajima, Masao, et al. "A Phase I Study of Multi-HLA-binding Peptides Derived From Heat Shock Protein 70/glypican-3 and a Novel Combination Adjuvant of HLAG-3Ig and Poly-ICLC for Patients With Metastatic Gastrointestinal Cancers: YNP01 Trial." Cancer Immunol Immunother 2020.
Cita MLANakajima, Masao, et al. "A Phase I Study of Multi-HLA-binding Peptides Derived From Heat Shock Protein 70/glypican-3 and a Novel Combination Adjuvant of HLAG-3Ig and Poly-ICLC for Patients With Metastatic Gastrointestinal Cancers: YNP01 Trial." Cancer Immunol Immunother 2020.